Multiple Kinase Cascades Mediate Prolactin Signals to Activating Protein-1 in Breast Cancer Cells
Open Access
- 1 December 2004
- journal article
- other
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 18 (12) , 3064-3075
Abstract
The importance of prolactin (PRL) in physiological proliferation and differentiation of the mammary gland, together with high levels of PRL receptors in breast tumors, the association of circulating PRL with incidence of breast cancer, and the recognition of locally produced PRL, point to the need for greater understanding of PRL actions in mammary disease. Although PRL has been shown to activate multiple kinase cascades in various target cells, relatively little is known of its signaling pathways in the mammary gland apart from the Janus kinase 2/ signal transducer and activator of transcription 5 pathway, particularly in tumor cells. Another potential effector is activating protein-1 (AP-1), a transcription complex that regulates processes essential for neoplastic progression, including proliferation, survival and invasion. We demonstrate that PRL activates AP-1 in MCF-7 cells, detectable at 4 h and sustained for at least 24 h. Although Janus kinase 2 and ERK1/2 are the primary mediators of PRL-induced signals, c-Src, phosphatidylinositol 3′-kinase, protein kinase C, and other MAPKs contribute to maximal activity. PRL activation of these pathways leads to increased c-Jun protein and phosphorylation, JunB protein, and phosphorylation of c-Fos, elevating the levels of AP-1 complexes able to bind DNA. These active AP-1 dimers may direct expression of multiple target genes, mediating some of PRL’s actions in mammary disease.Keywords
This publication has 59 references indexed in Scilit:
- Phosphorylation of the Carboxyl-Terminal Transactivation Domain of c-Fos by Extracellular Signal-Regulated Kinase Mediates the Transcriptional Activation of AP-1 and Cellular Transformation Induced by Platelet-Derived Growth FactorMolecular and Cellular Biology, 2003
- AP-1 complexes containing cJun and JunB cause cellular transformation of Rat1a fibroblasts and share transcriptional targetsOncogene, 2003
- Accessory Elements, Flanking DNA Sequence, and Promoter Context Play Key Roles in Determining the Efficacy of Insulin and Phorbol Ester Signaling through the Malic Enzyme and Collagenase-1 AP-1 MotifsJournal of Biological Chemistry, 2002
- Promoter Specificity and Biological Activity of Tethered AP-1 DimersMolecular and Cellular Biology, 2002
- AP-1 as a regulator of cell life and deathNature Cell Biology, 2002
- AP-1 blockade inhibits the growth of normal and malignant breast cellsOncogene, 2001
- AP-1 in mouse development and tumorigenesisOncogene, 2001
- Alterations in the gene expression profile of MCF-7 breast tumor cells in response to c-JunInternational Journal of Cancer, 2000
- cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotypeOncogene, 1999
- Activation and inhibition of the AP-1 complex in human breast cancer cellsMolecular Carcinogenesis, 1996